HEDS articles in 2012

The short story is there were 91 of them.  The long story is that they were:

1. Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type a: Results from the botulinum toxin for the upper limb after stroke (BoTULS) trial
2. Systematic review and narrative synthesis of the effectiveness of contraceptive service interventions for young people, delivered in health care settings
3. Assessing the health benefits of advice services: using research evidence and logic model methods to explore complex pathways
4. Brief Report: Preliminary Evidence of Reduced Sensitivity in the Peripheral Visual Field of Adolescents with Autistic Spectrum Disorder
5. Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence
6. Modelling the Cost-Effectiveness of Alcohol Screening and Brief Interventions in Primary Care in England.
7. THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30
8. Bevacizumab for Metastatic Colorectal Cancer A NICE Single Technology Appraisal
9. Reappraisal of the options for colorectal cancer screening in England
10. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation
11. Payers' views on treating-to-target in rheumatoid arthritis: an English perspective
12. The HubBLe trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for haemorrhoids
13. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation
14. The appropriateness of, and compliance with, telephone triage decisions: a systematic review and narrative synthesis
15. Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis
16. Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy
17. An assessment of the construct validity of the ASCOT measure of social care-related quality of life with older people
18. Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies
19. THE DEVELOPMENT AND VALUATION OF THE SHEFFIELD PREFERENCE BASED LEG ULCER QUESTIONNAIRE (SPVU-5D)
20. THE DEVELOPMENT OF AN INTERNATIONALLY-VALID CANCER-SPECIFIC MULTI-ATTRIBUTE UTILITY INSTRUMENT (MAUI) FROM THE EORTC CORE HEALTH-RELATED QUALITY OF LIFE (HRQOL) QUESTIONNAIRE, QLQ-C30
21. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
22. Outcomes of social care for adults: developing a preference-weighted measure
23. Response to Comments on Mulhern et al., "Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State
24. Monitoring outcomes for the medicare advantage program: Methods and application of the VR-12 for evaluation of plans
25. Estimating quality-adjusted life years from patient-reported visual functioning
26. Estimating a Preference-Based Index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): Valuation of CORE-6D.
27. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer
28. Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial
29. Heart-type fatty acid binding protein as an early marker for myocardial infarction: Systematic review and meta-analysis
30. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: A systematic review and economic evaluation
31. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review
32. COST-EFFECTIVENESS OF PRESENTATION AND DELAYED TROPONIN TESTING FOR ACUTE MYOCARDIAL INFARCTION
33. THE CLINICAL UTILITY AND COST-EFFECTIVENESS OF NON-INVASIVE TESTS FOR DETECTING FIBROSIS IN PATIENTS WITH SUSPECTED ALCOHOL-RELATED LIVER DISEASE
34. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction
35. A Model of the Cost-effectiveness of Intensity-modulated Radiotherapy in Comparison with Three-dimensional Conformal Radiotherapy for the Treatment of Localised Prostate Cancer
36. A Model of the Cost-effectiveness of Intensity-modulated Radiotherapy in Comparison with Three-dimensional Conformal Radiotherapy for the Treatment of Localised Prostate Cancer
37. Beyond PICO: The SPIDER Tool for Qualitative Evidence Synthesis
38. Whole disease modeling to inform resource allocation decisions in cancer: A methodological framework
39. The use of qualitative methods in developing the descriptive systems of preference-based measures of health-related quality of life for use in economic evaluation
40. Measuring and valuing health benefits for economic evaluation in adolescence: An assessment of the practicality and validity of the child health utility 9d in the australian adolescent population
41. Tilt testing is more cost-effective than implantable loop recorder monitoring as a means of directing pacing therapy in people with recurrent episodes of suspected vasovagal syncope that affect their quality of life or present a high risk of injury
42. Valuation of the Child Health Utility 9D Index
43. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model
44. Laparoscopic adjustable gastric banding vs standard medical management in obese patients with type 2 diabetes: a budget impact analysis in the UK.
45. Losing Sight of the Wood for the Trees Some Issues in Describing and Valuing Health, and Another Possible Approach
46. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication
47. The appropriateness of, and compliance with, telephone triage decisions: A systematic review and narrative synthesis
48. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication
49. A LITERATURE REVIEW OF EMPIRICAL STUDIES OF PROCESS UTILITY
50. Parathyroidectomy in a district general hospital: Outcomes and evolution in the era of minimally invasive surgery
51. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
52. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review
53. Minimally invasive oesophagectomy versus open surgery: is there an advantage?
54. COST-EFFECTIVENESS MODELLING OF TYPE-1 DIABETES
55. The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies
56. Modeling Using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
57. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity
58. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis
59. Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values
60. Principles of health economic evaluations of lipid-lowering strategies
61. Estimating Health State Utility Values for Joint Health Conditions: A Conceptual Review and Critique of the Current Evidence.
62. Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies
63. Economic analysis of potentially avoidable hospital admissions in patients with palliative care needs
64. Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy
65. Where is the evidence for emergency planning: a scoping review
66. PUBLIC PREFERENCES FOR RESPONSIBILITY VERSUS PUBLIC PREFERENCES FOR REDUCING INEQUALITIES
67. Computer therapy compared with usual care for people with long-standing aphasia poststroke: a pilot randomized controlled trial.
68. Should We Exclude Inadequately Reported Studies From Qualitative Systematic Reviews? An Evaluation of Sensitivity Analyses in Two Case Study Reviews
69. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
70. Barriers and facilitators to the use of high-technology augmentative and alternative communication devices: a systematic review and qualitative synthesis
71. Improvement in Nutritional Status Reduces the Clinical Impact of Infections in Older Adults
72. What type of leader am I?: A training needs analysis of health library and information managers
73. Women's perceptions and experiences of group cognitive behaviour therapy and other group interventions for postnatal depression: a qualitative synthesis
74. The hospital environment for end of life care of older adults and their families: An integrative review
75. Predicting increases in bed capacity for haematopoietic stem cell transplantation or intensive chemotherapy through simulation modelling of ambulatory care
76. Mapping the Functional Assessment of Cancer Therapy-General or - Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm
77. Know your RO from your AE? Learning styles in practice
78. Systematic Approaches to a Successful Literature Review
79. A comparison of alternative variants of the lead and lag time tto
80. HEALTH CARE RESOURCE UTILIZATION (HCRU) AND COSTS AMONG PATIENTS TREATED FOR NOSOCOMIAL PNEUMONIA (NP) CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (MRSA): SECONDARY ANALYSIS OF A MULTI-CENTER RANDOMIZED CONTROLLED STUDY
81. THE VALIDATION OF THE DIABETES HEALTH PROFILE (DHP-18) AND THE DEVELOPMENT OF A BRIEF MEASURE OF HEALTH RELATED QUALITY OF LIFE IN DIABETES (DHP-12)
82. Inconsistencies in NICE guidance for acupuncture: reanalysis and discussion
83. Testing the Consolidated Framework for Implementation Research on health care innovations from South Yorkshire
84. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores
85. It is the lifetime that matters: public preferences over maximising health and reducing inequalities in health
86. ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
87. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update
88. Economic analysis of the randomised assessment of treatment using panel assay of cardiac markers - contemporary biomarker evaluation study (RATPAC CBE)
89. To examine the diagnostic accuracy of highly sensitive troponin assays using diagnosis based on the universal definition of myocardial infarction in the unselected emergency room population
90. The diagnostic accuracy of novel biomarkers of myocardial injury in the unselected emergency room population
91. COST-EFFECTIVENESS ANALYSIS OF THREE YEAR VERSUS ONE YEAR IMATINIB FOR THE TREATMENT OF PATIENTS AT HIGH RISK OF DISEASE RECURRENCE FOLLOWING SURGICAL RESECTION OF KIT (CD117) POSITIVE GASTROINTESTINAL STROMAL TUMOURS (GIST)